Efficacy of MK0557 in Combination With Sibutramine or Orlistat

This study has been completed.

First Received: September 19, 2007 No Changes Posted

Sponsored by:	Merck
Information provided by:	Merck
ClinicalTrials.gov Identifier:	NCT00533481

Purpose

Study medicine will be given alone, or in combination with either sibutramine or orlistat, to obese subjects to compare the effect on body weight over a six month period.

Condition	Intervention	Phase
Obesity	Drug: MK0557	Phase II

MedlinePlus related topics: Obesity

Drug Information available for: MK 0557

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Randomized, Double-Blind, Placebo Control, Factorial Assignment, Safety/Efficacy Study

Further study details as provided by Merck:

Study Start Date:	December 2003
Study Completion Date:	December 2003

Eligibility

Ages Eligible for Study:	18 Years to 65 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Men and women between the ages of 18-65 who are considered obese (have a body mass index between 30 and 43)

Exclusion Criteria:

Subject has high blood pressure or is taking any high blood pressure medicine
History of psychiatric disorder, stroke, or heart disease

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00533481

Sponsors and Collaborators

Merck

Investigators

Study Director:

Medical Monitor

Merck

More Information

No publications provided

Study ID Numbers:	2007_615
Study First Received:	September 19, 2007
Last Updated:	September 19, 2007
ClinicalTrials.gov Identifier:	NCT00533481 History of Changes
Health Authority:	United States: Food and Drug Administration

Study placed in the following topic categories:

Sibutramine
Body Weight
Signs and Symptoms
Obesity

Orlistat
Nutrition Disorders
Overweight
Overnutrition

Additional relevant MeSH terms:

Body Weight
Signs and Symptoms
Obesity

Nutrition Disorders
Overweight
Overnutrition

ClinicalTrials.gov processed this record on May 07, 2009